While ABT263 had little impact on mitochondrial oxygen consumption rate, this effect was more pronounced in GBM cells treated with Crizotinib, indicating that c-MET inhibition likely has a direct impact on cellular respiration in human GBM cells (Fig. 4A). Here, MET is linked to glioblastoma.